
Peter G. Collin, MD
Advertisement
Collin is a second-year infectious diseases fellow at Beth Israel Deaconess Medical Center.
Articles by Peter G. Collin, MD


The significance of antiretroviral therapy (ART) has been a game changer for people living with HIV (PLWH). Still, there are some cardiovascular risks associated with different ART classes—particularly protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase strand transfer inhibitors (INSTIs). Authors review a piece in the literature around this area of study.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Rapid HCV Test Provides Opportunity for Single Visit Diagnosis and Treatment Encounters
2
No Negative Impact for Individuals Taking Lenacapavir and Gender-Affirming Hormone Therapy
3
Phage and Antibiotic Combination Therapy for Biofilm-Associated Bacterial Infections
4
Clinical Takeaways From ViiV’s PASO DOBLE and CLARITY Studies
5

